FIELD: medicine, pharmaceutics.
SUBSTANCE: dosage form contains oxycodone hydrochloride as a physiologically active substance (A), optionally one or more physiologically combined excipients (B), a synthetic or natural polymer (C) and optionally natural, semisynthetic or synthetic wax (D).
EFFECT: dosage form of oxycodone hydrochloride possess degradation resistance of at least 400 N to less than 500 N, and releases max 99% of oxycodone hydrochloride in the physiological conditions after 5 h.
14 cl, 7 dwg, 17 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EXTENDED RELEASE DURABLE DOSAGE FORMS | 2006 |
|
RU2399371C2 |
| MEDICINAL FORM PROTECTED AGAINST NON-INTENDED USE | 2004 |
|
RU2354357C2 |
| DRUG DOSAGE FORM, PROTECTED FROM UNINTENDED APPLICATION | 2004 |
|
RU2339365C2 |
| DESTRUCTION-RESISTANT DOSAGE FORM CONTAINING ANIONIC POLYMER | 2011 |
|
RU2607499C2 |
| DOSAGE FORM PROTECTED FROM UNINTENDED USE AND CONTAINING (1R, 2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)PHENOL | 2005 |
|
RU2393847C2 |
| OXIDATION STABLE AND BREAKING RESISTANCE DOSAGE FORM | 2010 |
|
RU2567723C2 |
| MISUSE PROTECTED DOSAGE FORM FOR OXIDATION SENSITIVE OPIOIDS | 2010 |
|
RU2555531C2 |
| PROTECTED AGAINST UNADMINISTERED APPLICATION PERORAL MEDICATION FORM | 2005 |
|
RU2396944C2 |
| HOT-MELT EXTRUDED PHARMACEUTICAL DOSAGE FORM | 2010 |
|
RU2547555C2 |
| DRUG FORM | 2009 |
|
RU2493830C2 |
